Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth (Status and Outlook) 2019-2024

Table of Contents

2019-2024 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2014-2024
2.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Size CAGR by Region
2.2 Cancer Immunotherapy Drug Discovery Outsourcing Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Immunomodulators
2.2.3 Oncolytic Viral Therapies and Cancer Vaccines
2.2.4 Other
2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
2.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2014-2019)
2.3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (2014-2019)
2.4 Cancer Immunotherapy Drug Discovery Outsourcing Segment by Application
2.4.1 Lung
2.4.2 Breast
2.4.3 Colorectal
2.4.4 Melanoma
2.4.5 Prostate
2.4.6 Head and Neck
2.4.7 Ovarian
2.4.8 Pancreatic
2.5 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
2.5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2014-2019)
2.5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application (2014-2019)

3 Global Cancer Immunotherapy Drug Discovery Outsourcing by Players
3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Players
3.1.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Players (2017-2019)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Players (2017-2019)
3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Cancer Immunotherapy Drug Discovery Outsourcing by Regions
4.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Regions
4.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth
4.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth
4.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth
4.5 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth

5 Americas
5.1 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Countries
5.2 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
5.3 Americas Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Countries
6.2 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
6.3 APAC Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing by Countries
7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing by Countries
8.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
8.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast
10.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Forecast (2019-2024)
10.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Regions
10.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Type
10.8 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast by Application

11 Key Players Analysis
11.1 Aquila BioMedical
11.1.1 Company Details
11.1.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Aquila BioMedical News
11.2 BPS Bioscience, Inc.
11.2.1 Company Details
11.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 BPS Bioscience, Inc. News
11.3 Celentyx Ltd
11.3.1 Company Details
11.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Celentyx Ltd News
11.4 Crown Bioscience, Inc.
11.4.1 Company Details
11.4.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Crown Bioscience, Inc. News
11.5 DiscoverX Corporation
11.5.1 Company Details
11.5.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 DiscoverX Corporation News
11.6 Explicyte
11.6.1 Company Details
11.6.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Explicyte News
11.7 Genscript Biotech Corporation
11.7.1 Company Details
11.7.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Genscript Biotech Corporation News
11.8 HD Biosciences Co.
11.8.1 Company Details
11.8.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 HD Biosciences Co. News
11.9 Horizon Discovery Group PLC
11.9.1 Company Details
11.9.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Horizon Discovery Group PLC News
11.10 ImmunXperts SA
11.10.1 Company Details
11.10.2 Cancer Immunotherapy Drug Discovery Outsourcing Product Offered
11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 ImmunXperts SA News
11.11 Molecular Imaging, Inc.
11.12 Promega Corporation,Personalis, Inc.
11.13 STC Biologics

12 Research Findings and Conclusion

Research Process

The research starts with the extensive procurement process of data/information and statistics from company annual reports, government websites, statistic agencies, and paid databases. This information creates a base for the study. This information also helps to define the scope and to narrow down the area for study for the market. This raw information is processed and analysed to extract crisp data points which currently affect or are likely to affect the industry over the forecast period. After analysing the information, a proprietary market estimation & forecast technique is applied, which generates the quantitative figures/sizes of the market/sub-segments in the current scenario as well as for over the forecast period. After populating the market sizes & estimates, numbers are verified with the industry participants and key opinion leaders. The wide network of industry participants performs a value addition in the research and verify the numbers & estimates of the study. In the last stage of the research process, a final report is prepared which is then published on different websites as well as distributed through various channels. Below figure contains the different stages of the whole research performed to produce the report.

After populating the market sizes & estimates, numbers are verified with the industry participants and key opinion leaders. The wide network of industry participants performs a value addition in the research and verify the numbers & estimates of the study. In the last stage of the research process, a final report is prepared which is then published on different websites as well as distributed through various channels. Below figure contains the different stages of the whole research performed to produce the report.

DATA MINING

Data mining is one of the extensive stages of our research process. It involves the procurement of market data and related information through different verified & credible sources. This step helps to obtain the raw information about the supply chain of the industry, the monetary process of different Products & End-Uses, the pool of market participants & the nature of the industry and the scope of the study. The data mining stage comprises both primary as well as secondary sources of information. Some of the key data sources are as follows:

Secondary Research In the process of secondary research, various sources are referred to identify and collect industry trends and information for the research process. We at having access to some of the most diversified and extensive paid databases which give us the most accurate data/information on markets sizes, Products and pricing.

In the primary research process for data mining, various key industry participants from both supply and demand side are interviewed to obtain both qualitative as well as quantitative information on the market. In-depth interviews with key primary respondents, including industry professionals, subject matter experts (SMEs), industry consultants, and C-level executives of major companies are conducted to obtain critical qualitative and quantitative aspects pertaining to the market, as well as to assess the prospects for market growth over the forecast period.

ANALYSIS

This step involves the analysis & mapping of all the information procured from the previous step. This step also encompasses the scrutiny of data discrepancies observed across various data sources and finalising the appropriate data for estimation and forecasting. This analysis is done by our experienced panel of industry analysts.

MARKET ESTIMATION

Understanding and penetrating the market in terms of valuation is a crucial task in the process of business research. This again becomes significantly important while investing and choosing the business opportunities. In this regard, we perform two ways market sizing approach simultaneously namely top-down and bottom-up approaches. In this step, we place different data points, numeric attributes, information, and industry trends at an appropriate space in order to deduce the estimates & forecast values over the coming years. We use different mathematical models to estimate the market sizes of different economies and segments. Each of which is further summed up to define the total market. We own a proprietary tool for market estimations which helps us to comprehend market size estimates & forecasts for different markets and industries. Below figure explains the process of market estimation using independent tool employed by our analysts to get the sizing off the market.